Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

Abstract Background Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project aimed to standardize medical practice using qu...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Kayo Ichihashi, Hikaru Hori, Naomi Hasegawa, Yuka Yasuda, Tomoya Yamamoto, Takashi Tsuboi, Kunihiro Iwamoto, Taishiro Kishimoto, Tadasu Horai, Hiroki Yamada, Nobuhiro Sugiyama, Toshinori Nakamura, Naohisa Tsujino, Kiyotaka Nemoto, Satoru Oishi, Masahide Usami, Eiichi Katsumoto, Hidenaga Yamamori, Hiroaki Tomita, Taro Suwa, Ryuji Furihata, Takahiko Inagaki, Junichi Fujita, Toshiaki Onitsuka, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Yuki Matsui, Yoshikazu Takaesu, Naoki Hashimoto, Junichi Iga, Kazuyoshi Ogasawara, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Ryota Hashimoto
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wiley 2020-09-01
Sarja:Neuropsychopharmacology Reports
Aiheet:
Linkit:https://doi.org/10.1002/npr2.12122